Related Experiment Videos
Depression, Hopelessness, and suicidal ideation in the terminally ill
H M Chochinov1, K G Wilson, M Enns
1Department of Psychiatry, University of Manitoba, Winnipeg, Canada.
Psychosomatics
|August 6, 1998
Summary
Hopelessness significantly predicts suicidal ideation in advanced cancer patients, more so than depression. Identifying hopelessness is crucial for healthcare providers caring for terminally ill patients.
Area of Science:
- Psychiatry and Psychology
- Palliative Care
- Oncology
Background:
- Suicidal ideation is a significant concern in patients with advanced terminal cancer.
- Understanding predictors of suicidal ideation is critical for effective clinical intervention in palliative care.
- The role of hopelessness versus depression in predicting suicidal ideation requires further investigation in this population.
Purpose of the Study:
- To investigate the mediational role of hopelessness in predicting suicidal ideation among patients with advanced terminal cancer.
- To compare the predictive power of hopelessness and depression levels on suicidal ideation.
Main Methods:
- A cohort of 196 patients with advanced terminal cancer participated in the study.
- Data were collected through semistructured interviews assessing hopelessness and suicidal ideation.
- The Beck Depression Inventory (short form) was administered to measure depression levels.
Main Results:
- Hopelessness demonstrated a higher correlation with suicidal ideation compared to depression.
- Multiple linear-regression analyses revealed that hopelessness uniquely predicted suicidal ideation, even when controlling for depression.
- Hopelessness emerged as a significant independent predictor of suicidal ideation.
Conclusions:
- Hopelessness is a critical clinical marker for identifying suicidal ideation in terminally ill cancer patients.
- Healthcare providers should assess hopelessness as a priority in managing the psychological well-being of dying patients.
- Targeting hopelessness may be a key strategy in suicide prevention among advanced cancer patients.